Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
1,180
-11
-0.9% -$2.37K 0.06% 191
2026
Q1
$259K Sell
1,191
-48
-4% -$10.6K 0.08% 184
2025
Q4
$283K Buy
+1,239
New +$282K 0.09% 151
2025
Q3
Sell
-1,271
Closed -$236K 142
2025
Q2
$236K Buy
1,271
+133
+12% +$24.7K 0.07% 155
2025
Q1
$238K Sell
1,138
-9
-0.8% -$1.75K 0.09% 141
2024
Q4
$204K Sell
1,147
-398
-26% -$73.2K 0.07% 142
2024
Q3
$305K Sell
1,545
-46
-3% -$8.59K 0.12% 111
2024
Q2
$273K Buy
1,591
+233
+17% +$38.6K 0.11% 102
2024
Q1
$247K Buy
+1,358
New +$234K 0.11% 97

Other funds holding ABBV

SMART Wealth's ABBV Position: Q2 2026 in Review

SMART Wealth reduced its AbbVie (ABBV) stake by 0.92% in Q2 2026, selling an estimated $2.37K and leaving 1,180 shares worth $297K. The position accounts for 0.06% of the portfolio, ranked #191.

SMART Wealth first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $305K in Q3 2024. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SMART Wealth held 1,180 shares of AbbVie worth $297K as of Q2 2026.
  • SMART Wealth sold 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.06% of SMART Wealth's portfolio in Q2 2026, its #191 holding.
  • SMART Wealth first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • SMART Wealth's AbbVie position peaked at $305K in Q3 2024.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SMART Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.